Description
The CJC-1295 + Ipamorelin Blend combines a GHRH analogue (CJC-1295 no DAC) with a GHRP agonist (Ipamorelin) in a single lyophilized vial. This combination is commonly used in research examining the synergistic effects of simultaneous GHRH and ghrelin receptor activation on pituitary somatotroph signalling and GH pulse amplitude in cell and animal models.
Available as 5+5 mg blend, ≥98% combined purity, COA included.
| Format | Lyophilized powder |
|---|---|
| Purity | ≥98% HPLC |
| Storage | −20°C desiccated |
Research Use Only. Not for human or veterinary use.




